麦斯莫医疗(MASI)
icon
搜索文档
Masimo's (MASI) New Offering to Serve Personalized Audio Market
zacks.com· 2024-05-21 02:21
Masimo Corporation (MASI) , along with Denon, recently announced the introduction of White PerL. It is the latest offering of its Denon PerL and Denon PerL Pro True Wireless earbud line-up from the Denon PerL product lines. The latest announcement is expected to significantly solidify Masimo’s foothold in the global personalized hearables market, thereby boosting its non-healthcare consumer audio business. Significance of the Launch Per Masimo, the two Denon PerL models are engineered with the company’s pro ...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Masimo Corporation - MASI
prnewswire.com· 2024-05-17 05:35
NEW YORK, May 16, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Masimo Corporation ("Masimo" or the "Company") (NASDAQ: MASI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Masimo and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On May 7, 2024, Masimo di ...
Investigation Into Masimo Corporation (MASI) Announced by Holzer & Holzer, LLC
Newsfilter· 2024-05-15 04:46
ATLANTA, May 14, 2024 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Masimo Corporation ("Masimo" or the "Company") (NASDAQ:MASI) complied with federal securities laws. On May 7, 2024, Masimo disclosed that it "received a subpoena from the Department of Justice (DOJ) dated February 21, 2024 seeking documents and information related to the Company's Rad-G® and Rad-97® products, including information relating to complaints surrounding the products and the Company's decision to recall select ...
Masimo seeks to stave off proxy fight with Politan, makes settlement offer
CNBC· 2024-05-10 01:39
The Masimo logo is displayed at Masimo headquarters on December 27, 2023 in Irvine, California. Health-technology firm Masimo, facing the imminent threat of litigation and a second proxy contest, offered a settlement to Politan Capital's Quentin Koffey on Thursday that would fill a vacant board seat with one of the activist's proposed directors. Masimo's lead independent director Craig Reynolds said he hoped adding Politan's nominee William Jellison to the company's board would help "avoid the significant d ...
Masimo activist director Koffey demands ‘basic' information on company's proposed spinoff
CNBC· 2024-05-09 07:27
Politan Capital's Quentin Koffey sent a letter to Masimo CEO Joe Kiani on Wednesday, demanding information about the health-tech company's proposed spinoff of its consumer business. Koffey, who won a seat on Masimo's board last year through a proxy fight, said that, despite his "repeated requests," he has "not received information as basic and fundamental as even the name of the contemplated JV partner," weeks after the company first announced it was exploring a split. Masimo acquired consumer audio company ...
Masimo (MASI) Q1 Earnings Beat Estimates, '24 EPS View Up
Zacks Investment Research· 2024-05-09 00:31
Masimo Corporation (MASI) delivered adjusted earnings per share (EPS) of 77 cents in the first quarter of 2024, down 11.5% year over year. The figure, however, beat the Zacks Consensus Estimate by 8.5%. The adjustments include acquisition, integration and related costs, and litigation-related expenses, settlements and awards, among others. GAAP EPS was 35 cents, down 10.3% from the year-earlier figure. Revenues in Detail Masimo registered revenues of $492.8 million, down 12.8% year over year on a reported b ...
Masimo(MASI) - 2024 Q1 - Earnings Call Transcript
2024-05-08 09:40
财务数据和关键指标变化 - 第一季度公司实现收入4.93亿美元,其中医疗保健收入3.4亿美元,达到指导范围的上限,同比下降2% [13] - 医疗保健耗材和服务收入同比增长2%,抵消了资本设备和其他收入同比下降21% [14] - 公司实现非GAAP毛利率52%,其中医疗保健业务毛利率62%,非医疗保健业务毛利率29% [19] - 公司实现非GAAP营业利润6800万美元,非GAAP每股收益0.77美元 [19] - 公司经营活动产生现金流4600万美元,用于偿还2800万美元债务 [20] 各条业务线数据和关键指标变化 - 脉搏血氧仪耗材收入同比增长2%,受到较高的去年同期基数影响 [15] - 呼吸监测耗材收入同比增长27%,占该类收入一半以上 [15] - 脑电监测传感器收入同比增长17%,SedLine和O3产品持续获得市场份额 [15] - 彩虹系列耗材收入同比下降11%,受到美国以外地区发货时间的影响 [15] 各个市场数据和关键指标变化 - 美国和欧洲市场脉搏血氧仪订单强劲,推动医疗保健收入达到指导范围上限 [9] - 公司在医院客户中实现超过1亿美元的真实增量合同价值,显示市场份额持续增加 [9] 公司战略和发展方向及行业竞争 - 公司正在评估分拆消费者业务的可行性,目标是使两个业务获得适当的资本结构和资源,实现长期成功和股东价值最大化 [26][27] - 分拆后,医疗保健业务将保留远程医疗和居家医疗监护产品,这些产品正受到医院和医疗服务提供商的广泛关注 [34] - 分拆后,医疗保健业务的非GAAP营业利润率有望提升220-380个基点,达到23%-25%,接近30%的长期目标 [27] 管理层对经营环境和未来前景的评论 - 公司业务已重回正轨,医疗保健收入和非GAAP每股收益指引均有所提升 [8][23] - 医疗保健业务的强劲订单和大幅增加的未确认合同收入,给予公司信心实现收入增长目标 [16][20] - 将近2/3的传感器生产已转移至马来西亚,有助于进一步提升毛利率 [9][22] - 医院就诊人数有望在2024年保持0%-1%的增长,为公司业务增长提供支持 [63] 问答环节重要的提问和回答 问题1 **Rick Wise 提问** 询问第一季度设备出货量大幅下降至5万台的原因,以及后续季度预期恢复至6万台以上的依据 [38][39] **Micah Young 回答** 出货量下降主要是由于OEM客户订单大幅下降,但公司直销设备需求仍然强劲。公司预计第二季度出货量将超过5.5万台,第三四季度将恢复至6万台以上,反映了市场需求的恢复 [39][40] 问题2 **Marie Thibault 提问** 询问分拆后医疗保健业务的营业利润率大幅提升的原因 [51] **Micah Young 回答** 分拆后将剥离消费者音频业务,约7.4亿美元收入和2900万美元利润。此外还将剥离部分研发费用,预计可提升医疗保健业务营业利润率220-380个基点至23.2%-24.8% [52][53] 问题3 **Vik Chopra 提问** 询问公司何时将向董事会提出分拆方案选项 [59] **Micah Young 回答** 公司正在加快内部评估工作,预计在未来30-45天内将取得重大进展,并向董事会提出分拆方案选项 [62]
Masimo (MASI) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Zacks Investment Research· 2024-05-08 08:30
Masimo (MASI) reported $492.8 million in revenue for the quarter ended March 2024, representing a year- over-year decline of 12.8%. EPS of $0.77 for the same period compares to $0.87 a year ago. The reported revenue represents a surprise of +0.95% over the Zacks Consensus Estimate of $488.18 million. With the consensus EPS estimate being $0.71, the EPS surprise was +8.45%. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street ...
Masimo(MASI) - 2024 Q1 - Quarterly Results
2024-05-08 04:08
Exhibit 99.1 Masimo Reports First Quarter 2024 Financial Results First Quarter 2024 Highlights: • Consolidated revenue was $492.8 million; • Healthcare revenue was $339.6 million; • Non-healthcare revenue was $153.2 million; • GAAP net income per diluted share was $0.35; and • Non-GAAP net income per diluted share was $0.77. Irvine, California, May 7, 2024 - Masimo Corporation (Nasdaq: MASI) today announced its financial results for the first quarter ended March 30, 2024. First Quarter 2024 Results: Consoli ...
Masimo's billionaire CEO put shares on margin to get cash while keeping ownership ahead of proxy fight
CNBC· 2024-05-02 04:05
Billionaire Masimo founder Joe Kiani, best known for his successful legal fight against Apple and his friendship with President Joe Biden, has borrowed against half of his $660 million stake in the health- technology company rather than sell his stock, according to corporate filings from earlier this week. Borrowing against that much of a stake is unusual for executives, but may be helpful as the company prepares for a fight with an activist aiming to take control of the board. The move allows Kiani, the co ...